p73: Friend or foe in tumorigenesis

By G. Melino, V. Laurenzi, Karen H. Vousden. Nature Reviews. Cancer, 2002

594 citations recorded by the source corpus.

Subfields: Biotechnology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/8f579a3efa9ab77dabe9938a04620052135f5c8e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biotechnology

1. Scott W. Lowe

In Molecular Biology

1. J. Fridman
2. Scott W. Lowe
3. J. Campisi

In Oncology

1. Scott W. Lowe
2. J. Fridman
3. J. Campisi

Citations in the corpus

• Control of apoptosis by p53 (2003, background): “Furthermore, the transactivation domain-deficient isoforms of p63 and p73 are overexpressed in some human tumors (see, for review, Moll et al., 2001; Melino et al., 2002; Benard et al., 2003), where they may act as dominant negatives or interfere with normal p53 function by forming mixed complexes…”
• p63 is upstream of IKKα in epidermal development (2006, background): “, 1998), a member of the p53 family (Melino et al., 2002; Melino et al., 2003; Yang et al., 2002; Yang and McKeon, 2000).”